Chinese vaccine manufacturer SINOVAC released real-world data on the company's COVID-19 vaccine, CoronaVac, addressing the vaccine's safety and efficacy for seniors, a key target group for China's continued push to improve vaccination rates, particularly for those aged 80 or above.